Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Palix Foundation has pledged £265,250 to support a cross-disciplinary project aimed at sharing scientific knowledge about early brain development and its effect on mental health and addiction. The project will be delivered by the Department of Psychiatry and the Department of Experimental Psychology, and will unite Oxford and the foundation's shared vision of improving outcomes for children, their families and future generations.

© THE BRAIN STORY © PALIX FOUNDATION / ALBERTA FAMILY WELLNESS INITIATIVE

Lifelong health is determined by more than just our genes: experiences early in life and at other sensitive periods of development can affect our brains in ways that may impact our health as we grow older. This knowledge has important implications for both policy and practice, but despite its significance, the science behind early brain development is not widely disseminated. Front-line staff may be unfamiliar with recent advances in the field, while parents have little exposure to the science underlying the growth of their children's brains.

The Palix Foundation seeks to bridge this gap. In 2010 the foundation began disseminating the Brain Story, a narrative framework that makes scientific knowledge about early brain development accessible to policy-makers, practitioners and the public. Developed by the FrameWorks Institute and the National Scientific Council of the Developing Child, the Brain Story is shared via tools, resources and a certification course, with the aim of building resilience in families and communities around the world.

With the foundation's support, a team of researchers at Oxford will now work to embed the Brain Story locally and beyond. Under the leadership of Alan Stein, Professor of Child and Adolescent Psychiatry at the University, the team will develop a programme to explore and evaluate different ways of implementing the Brain Story, thus maximising its reach and impact.

Read more (University of Oxford Development Office)

NIHR OXFORD HEALTH BIOMEDICAL RESEARCH CENTRE NEWS

Please follow the link below to read the news on the NIHR BRC website.

Similar stories

Improving Experiences of People with Serious Mental Health Problems

Mental Health

A project led by Professor Kam Bhui and Dr Roisin Mooney, University of Oxford, will focus on reducing the number of people admitted or readmitted to compulsory care under the Mental Health Act. This is one of four new research projects funded by the National Institute for Health Research (NIHR) with the aim to improve patient experiences and outcomes under the Mental Health Act.

Just Over Half of British Indians Would Get COVID Vaccine

COVID-19 Mental Health

University of Oxford researchers from the Department of Physiology, Anatomy and Genetics (DPAG) and the Department of Psychiatry, in collaboration with The 1928 Institute, have published a major new study on the impact of COVID-19 on the UK’s largest BME population.

Investigating New Treatment for Schizophrenia

Mental Health Schizophrenia

A partnership between University of Oxford, the Earlham Institute, and the global pharmaceutical companies Biogen Inc and Boehringer Ingelheim is announced today to investigate a new drug target for the treatment of schizophrenia.

Parental Mental Health Worse Since New National Restrictions

COVID-19 Child and adolescent Early intervention Mental Health Psychological therapy

Parental stress, depression, and anxiety have again increased since new national restrictions have been introduced according to the latest report from the Oxford University led COVID-19 Supporting Parents, Adolescents, and Children in Epidemics (Co-SPACE) study based on data from over 6000 UK parents.

Potential New Target to Prevent or Delay Dementia

Alzheimer's disease Dementia Mental Health Old-age psychiatry

New study shows targeting arterial stiffening earlier in a person’s lifespan could provide cognitive benefits in older age and may help to delay the onset of dementia.

SSRI Treatment in Young People with Depression and Anxiety

Anxiety Depression Mental Health

Results from an insight review commissioned by the Wellcome Trust, highlights what is currently known about the benefits and risks of using selective serotonin reuptake inhibitors (SSRIs) for the treatment of depression and anxiety in young people.